Ondansetron hydrochloride dihydrate
CAS: 99614-01-4
Ref. IN-DA0065JT
10mg | Descontinuado | ||
50mg | Descontinuado |
Informação sobre produto
Nome:
Ondansetron hydrochloride dihydrate
Sinónimos:
- [u'Dihydrate, Ondansetron Monohydrochloride', u'GR 38032F', u'GR-38032F', u'GR38032F', u'Hydrochloride, Ondansetron', u'Monohydrochloride Dihydrate, Ondansetron', u'Monohydrochloride, Ondansetron', u'Ondansetron', u'Ondansetron Hydrochloride', u'Ondansetron Monohydrochloride', u'Ondansetron Monohydrochloride Dihydrate', u'Ondansetron, (+,-)-Isomer', u'Ondansetron, (R)-Isomer', u'Ondansetron, (S)-Isomer', u'SN 307', u'SN-307', u'SN307', u'Zofran', u'ONDANSETRON HYDROCHLORIDE', u'ONDANSETRON HCl', u'99614-01-4', u'Zofran', u'Emeset', u'Ondansetron (Hydrochloride)', u'Emetron', u'Ondemet', u'SN 307', u'NSC 665799', u'ZOFRAN PRESERVATIVE FREE', u'CPD000469179', u'9-Methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-4H-carbazol-4-one monohydrochloride', u'C18H19N3O.HCl', u'Q-201515', u'9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one hydrochloride', u'4H-Carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-, monohydrochloride', u'9-METHYL-3-((2-METHYL-1H-IMIDAZOL-1-YL)METHYL)-2,3-DIHYDRO-1H-CARBAZOL-4(9H)-ONE HYDROCHLORIDE', u'SMR000469179', u'GR-38032F', u'GR 38032', u'SR-01000763250', u'Zofran and dextrose in plastic container', u'PubChem17490', u'Ondansetron hydrochloride preservative free', u'Ondansetron-hydrochloride', u'AC1Q3ERO', u'AC1L2A5S', u'SCHEMBL41455', u'MLS001304076', u'MLS001401397', u'MLS002222312', u'Ondemet;Emeset;Emetron;Zofran', u'REGID_for_CID_68647', u'GR 38032 HCl', u'Ondansetron hydrochloride, 98%', u'CHEMBL1201111', u'CTK8F0270', u'Ondansetron hydrochloride and dextrose in plastic container', u'MKBLHFILKIKSQM-UHFFFAOYSA-N', u'HMS1571C18', u'Ondansetron hydrochloride (Zofran)', u'HY-B0002', u'Ondansetron hydrochloride and sodium chloride in plastic container', u'BG0279', u'MFCD00764297', u'NSC665799', u's1390', u'AKOS015889292', u'AB07046', u'API0003688', u'CCG-100852', u'CCG-221058', u'CS-1715', u'GS-3597', u'H39O049', u'NC00102', u'NSC-665799', u'9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4h-carbazol-4-onhydrochlorid', u'AC-12464', u'BC204680', u'LS-51879', u'O739', u'SAM001246631', u'AB0016622', u'AB2000081', u'RT-014862', u'TL8000158', u'O0407', u'SW100810-5', u'VU0424014-2', u'A800774', u'I06-131', u'I01-1935', u'I06-0131', u'SR-01000763250-5', u'9-methyl-3-[(2-methyl-1-imidazolyl)methyl]-2,3-dihydro-1H-carbazol-4-one hydrochloride', u'9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-1,2,3,9-tetrahydro-4H-carbazol-4-one hydrochloride', u'9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-2,3,4,9-tetrahydro-1H-carbazol-4-one hydrochloride', u'Zophren', u'Zudan', u'Zofran ODT', u'UNII-NMH84OZK2B', u'UNII-2999F27MAD', u'GR 38032F', u'C18H19N3O.ClH.2H2O', u'2999F27MAD', u'C18-H19-N3-O.Cl-H', u'CID68647', u'AR-1H5870', u'Ondansetron hydrochloride [USAN:JAN]', u'103639-04-9', u'C18-H19-N3-O.Cl-H.2H2-O', u'Ondansetron hydrochloride [USAN:USP:JAN]', u'99614-02-5', u'1,2,3,9-Tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one hydrochloride', u'(+-)-2,3-Dihydro-9-methyl-3-((2-methylimidazol-1-yl)methyl)carbazol-4(1H)-one monohydrochloride dihydrate', u'6344-04-3']
- (+-)-2,3-Dihydro-9-Methyl-3-((2-Methylimidazol-1-Yl)Methyl)Carbazol-4(1H)-One Monohydrochloride Dihydrate
- 1,2,3,4-Tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-9H-carbazol-4-one hydrochloride
- 1,2,3,9-Tetrahydro-9-Methyl-3-[(2-Methyl-1H-Imidazol-1-Yl)Methyl]-4H-Carbazol-4-One Hydrochloride Dihydrate
- 1-methyl-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide hydrochloride (1:1)
- 4H-Carbazol-4-One, 1,2,3,9-Tetrahydro-9-Methyl-3-((2-Methyl-1H-Imidazol-1-Yl)Methyl)-, Monohydrochloride, (+-)-, Dihydrate
- 4H-Carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-, monohydrochloride
- 4H-Carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-, hydrochloride (1:1)
- 9-Methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-4H-carbazol-4-one monohydrochloride
- 9-Methyl-3-[(2-Methylimidazol-1-Yl)Methyl]-2,3-Dihydro-1H-Carbazol-4-One Dihydrate Hydrochloride
- Ver mais sinónimos
- 9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one hydrochloride (1:1)
- 9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one hydrochloride dihydrate
- Carbazol-4-One Dihydrate
- Emeset
- Gr 38032F
- NSC 665799
- Odansetron Hydrochloride Dihydrate
- Ondansetron HCl
- Ondansetron Hcl Dihydrate
- Ondansetron Hydrochloride Hydrate
- Ondansetron hydrochloride
- Osetron
- Sn 307
- Zofran
- Zofran ODT
- Zophren
- Zudan
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Indagoo
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
365.8545
Fórmula:
C18H24ClN3O3
Pureza:
98%
Cor/forma:
Solid
InChI:
InChI=1S/C18H19N3O.ClH/c1-12-19-9-10-21(12)11-13-7-8-16-17(18(13)22)14-5-3-4-6-15(14)20(16)2;/h3-6,9-10,13H,7-8,11H2,1-2H3;1H
Chave InChI:
MKBLHFILKIKSQM-UHFFFAOYSA-N
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS: